The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 26, Issue 7, Pages 752-765
Publisher
Wiley
Online
2017-03-27
DOI
10.1002/pds.4200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management
- (2016) Wan-Tseng Hsu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Quality of life of elderly people living in a retirement home
- (2016) Sonja Cankovic et al. Vojnosanitetski Pregled
- Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design
- (2015) F.M. de Vries et al. CURRENT MEDICAL RESEARCH AND OPINION
- P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
- (2015) Aizati N. A. Daud et al. DRUG SAFETY
- A metoprolol–terbinafine combination induced bradycardia
- (2014) Emmanuel Bebawi et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians
- (2014) K. P. Kerr et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
- (2014) Supinya Dechanont et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
- (2013) Julie Doan et al. ANNALS OF PHARMACOTHERAPY
- Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen
- (2013) Lisette Binkhorst et al. BREAST CANCER RESEARCH AND TREATMENT
- A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics
- (2013) C M Blake et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- TREATMENT OF DEPRESSION IN CARDIOVASCULAR DISEASE
- (2013) Nicole Mavrides et al. DEPRESSION AND ANXIETY
- Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis
- (2013) Koen B. Pouwels et al. DRUG SAFETY
- Differential Effects of Nebivolol Versus Metoprolol on Functional Sympatholysis in Hypertensive Humans
- (2013) Angela Price et al. HYPERTENSION
- Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts
- (2013) Rianne J. Zaal et al. International Journal of Clinical Pharmacy
- Complete Atrioventricular Block Associated With Concomitant Use of Metoprolol and Paroxetine
- (2012) Orhan Onalan et al. MAYO CLINIC PROCEEDINGS
- Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based Software
- (2011) Hubert Zakrzewski-Jakubiak et al. American Journal Geriatric Pharmacotherapy
- Cytochrome P450-mediated cardiovascular drug interactions
- (2011) André J Scheen Expert Opinion on Drug Metabolism & Toxicology
- A critical evaluation of clinical decision support for the detection of drug–drug interactions
- (2011) Pamela L Smithburger et al. Expert Opinion On Drug Safety
- Effects of Paroxetine on the Pharmacokinetics and Pharmacodynamics of Immediate-Release and Extended-Release Metoprolol
- (2011) Robert B Parker et al. PHARMACOTHERAPY
- Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol’s O-demethylation via CYP2D6
- (2010) Anette Green Nielsen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Age- and gender-specific prevalence of depression in latest-life – Systematic review and meta-analysis
- (2010) M. Luppa et al. JOURNAL OF AFFECTIVE DISORDERS
- The Impact of Paroxetine Coadministration on Stereospecific Carvedilol Pharmacokinetics
- (2010) Stephen M. Stout et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Influence of Metoprolol Dosage Release Formulation on the Pharmacokinetic Drug Interaction With Paroxetine
- (2010) Stephen M. Stout et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions
- (2009) Buster Mannheimer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacist-Based Medication Review Reduces Potential Drug-Related Problems in the Elderly
- (2009) Thijs H A M Vinks et al. DRUGS & AGING
- Drug safety alert generation and overriding in a large Dutch university medical centre
- (2009) Heleen van der Sijs et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants
- (2008) Monique J. Bijl et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction
- (2008) Ksenia Goryachkina et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Turning Off Frequently Overridden Drug Alerts: Limited Opportunities for Doing It Safely
- (2008) H. van der Sijs et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started